Impact of FDA Updates on Public Interest in Breast Implant-associated Anaplastic Large Cell Lymphoma

In the United States, the Food and Drug Administration (FDA) is responsible for protecting the public health by assuring the safety, efficacy, and security of drugs, biological products, and medical devices. In that role, FDA releases timely updates with regard to medical devices and their possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Mansher, Singh, Gayatri, Singh Chauhan, Anupam, Lee, Harrison H., Sacks, Justin M., Hultman, Charles S., Albert, Mark G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Breast
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722577/
https://www.ncbi.nlm.nih.gov/pubmed/33299706
http://dx.doi.org/10.1097/GOX.0000000000003240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722577/
https://www.ncbi.nlm.nih.gov/pubmed/33299706
http://dx.doi.org/10.1097/GOX.0000000000003240

Ejemplares similares